Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Oivi As |
| Country | Norway |
| Start Date | Jan 01, 2023 |
| End Date | Dec 31, 2024 |
| Duration | 730 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 190126744 |
Oivi provides affordable eye care for all and prevent unnecessary blindness by providing a low-cost camera for retinal (fundus) photography, with fully automated image capture and diagnostics. Oivi is a point-of-care device for eye screening of diabetic retinopathy (DR). DR affects >160 M people worldwide and is the most common cause of blindness among working-age adults.
Yet, early detection can successfully prevent vision-loss in 95% of the cases.
Current solutions for DR screening are expensive and require extensive training that limits accessibility to patients, especially in developing countries.
Oivi is a unique combination of automated, easy-to-use, low-cost and integrated Machine Learning/Artificial Intelligence solutions (for image capturing and DR diagnostic) in a highly portable design.
Within the iScan project, we want to mature the device and its diagnostic functionalities, to clinically validate our solution and to assure regulatory approvals.
Oivi As
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant